← FDA Drug Approvals (Drugs@FDA)

RIFAPENTINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS · Approved 2026-06-23

Drug application

FDA Application #

ANDA217042

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAPENTINE

Generic name

RIFAPENTINE

Active ingredients

RIFAPENTINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS

Manufacturer

Macleods Pharmaceuticals Limited

First approval

2026-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown